Initial antiretroviral therapy in chronically-infected HIV-positive adults

Zelalem Temesgen, Francesca Cainelli, David Warnke, Janak Koirala

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Currently, there are 20 individual antiretroviral drugs and two co-formulation products that are approved by the FDA for the treatment of HIV-infected individuals. It is widely accepted that the selection of an appropriate first-line regimen is critical in assuring durable treatment response. This article reviews the factors that should be considered in the selection of an initial antiretroviral regimen and present the currently available evidence regarding the status of individual antiretroviral agents and treatment strategies relative to these factors. 2004

Original languageEnglish
Pages (from-to)595-612
Number of pages18
JournalExpert Opinion on Pharmacotherapy
Volume5
Issue number3
DOIs
Publication statusPublished - Mar 2004
Externally publishedYes

Fingerprint

Anti-Retroviral Agents
HIV
Pharmaceutical Preparations
Therapeutics

Keywords

  • Antiretroviral drugs
  • Antiretroviral therapy
  • Highly active antiretroviral therapy (HAART)
  • Initial antiretroviral regimen

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Initial antiretroviral therapy in chronically-infected HIV-positive adults. / Temesgen, Zelalem; Cainelli, Francesca; Warnke, David; Koirala, Janak.

In: Expert Opinion on Pharmacotherapy, Vol. 5, No. 3, 03.2004, p. 595-612.

Research output: Contribution to journalReview article

Temesgen, Zelalem ; Cainelli, Francesca ; Warnke, David ; Koirala, Janak. / Initial antiretroviral therapy in chronically-infected HIV-positive adults. In: Expert Opinion on Pharmacotherapy. 2004 ; Vol. 5, No. 3. pp. 595-612.
@article{7e3adc1c07ce4eaf93e379293b905d13,
title = "Initial antiretroviral therapy in chronically-infected HIV-positive adults",
abstract = "Currently, there are 20 individual antiretroviral drugs and two co-formulation products that are approved by the FDA for the treatment of HIV-infected individuals. It is widely accepted that the selection of an appropriate first-line regimen is critical in assuring durable treatment response. This article reviews the factors that should be considered in the selection of an initial antiretroviral regimen and present the currently available evidence regarding the status of individual antiretroviral agents and treatment strategies relative to these factors. 2004",
keywords = "Antiretroviral drugs, Antiretroviral therapy, Highly active antiretroviral therapy (HAART), Initial antiretroviral regimen",
author = "Zelalem Temesgen and Francesca Cainelli and David Warnke and Janak Koirala",
year = "2004",
month = "3",
doi = "10.1517/14656566.5.3.595",
language = "English",
volume = "5",
pages = "595--612",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Initial antiretroviral therapy in chronically-infected HIV-positive adults

AU - Temesgen, Zelalem

AU - Cainelli, Francesca

AU - Warnke, David

AU - Koirala, Janak

PY - 2004/3

Y1 - 2004/3

N2 - Currently, there are 20 individual antiretroviral drugs and two co-formulation products that are approved by the FDA for the treatment of HIV-infected individuals. It is widely accepted that the selection of an appropriate first-line regimen is critical in assuring durable treatment response. This article reviews the factors that should be considered in the selection of an initial antiretroviral regimen and present the currently available evidence regarding the status of individual antiretroviral agents and treatment strategies relative to these factors. 2004

AB - Currently, there are 20 individual antiretroviral drugs and two co-formulation products that are approved by the FDA for the treatment of HIV-infected individuals. It is widely accepted that the selection of an appropriate first-line regimen is critical in assuring durable treatment response. This article reviews the factors that should be considered in the selection of an initial antiretroviral regimen and present the currently available evidence regarding the status of individual antiretroviral agents and treatment strategies relative to these factors. 2004

KW - Antiretroviral drugs

KW - Antiretroviral therapy

KW - Highly active antiretroviral therapy (HAART)

KW - Initial antiretroviral regimen

UR - http://www.scopus.com/inward/record.url?scp=1542609988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542609988&partnerID=8YFLogxK

U2 - 10.1517/14656566.5.3.595

DO - 10.1517/14656566.5.3.595

M3 - Review article

VL - 5

SP - 595

EP - 612

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

IS - 3

ER -